T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 10.5 THB -0.94%
Market Cap: 4.2B THB
Section:
 

Relative Value

The Relative Value of one TMAN stock under the Base Case scenario is hidden THB. Compared to the current market price of 10.5 THB, T Man Pharmaceutical PCL is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TMAN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
47
vs Industry
43
Median 3Y
1.9
Median 5Y
1.9
Industry
2.1
Forward
1.6
More Details
N/A
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
24
Median 3Y
0
Median 5Y
0
Industry
18.5
Forward
8.2
More Details
6
P/OCF
P/OCF
Price to OCF
6
vs History
47
vs Industry
18
Median 3Y
6
Median 5Y
6
Industry
11.2
More Details
4.9
P/FCFE
P/FCFE
Price to FCFE
4.9
vs History
47
vs Industry
23
Median 3Y
4.9
Median 5Y
4.9
Industry
14.3
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
76
vs Industry
22
Median 3Y
2.4
Median 5Y
2.4
Industry
1.8
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
41
vs Industry
45
Median 3Y
2
Median 5Y
2
Industry
3.2
Forward
1.7
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
41
vs Industry
46
Median 3Y
4
Median 5Y
4
Industry
6.9
More Details
32.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32.3
vs History
23
vs Industry
21
Median 3Y
7.1
Median 5Y
7.1
Industry
11.1
Forward
5.9
More Details
N/A
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
20
Median 3Y
0
Median 5Y
0
Industry
13.4
Forward
7
More Details
6.2
EV/OCF
EV/OCF
Enterprise Value to OCF
6.2
vs History
41
vs Industry
18
Median 3Y
6.3
Median 5Y
6.3
Industry
11.3
More Details
8.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.8
vs History
41
vs Industry
13
Median 3Y
8.8
Median 5Y
8.8
Industry
12.1
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
70
vs Industry
24
Median 3Y
2
Median 5Y
2
Industry
1.7
More Details

Multiples Across Competitors

TMAN Competitors Multiples
T Man Pharmaceutical PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
T Man Pharmaceutical PCL
SET:TMAN
4.2B THB 1.9 0 32.3 0
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
176.9B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
88.9B Zac 0 0 0 0
CH
Galderma Group AG
SIX:GALD
37.7B CHF 0 0 0 0
US
Reddit Inc
NYSE:RDDT
49B USD 25.7 140.4 167.8 178
US
Symbotic Inc
NASDAQ:SYM
41.4B USD 18.4 -2 442.5 -1 220.4 -553.6
US
CoreWeave Inc
NASDAQ:CRWV
42.7B USD 0 0 0 0
US
Coupang Inc
F:788
33.9B EUR 1.2 101.2 26.8 44.1
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
579.3T IDR 48.1 -132.7 2 800.4 2 800.4
P/S Multiple
Revenue Growth P/S to Growth
TH
T
T Man Pharmaceutical PCL
SET:TMAN
Average P/S: 74.5
1.9
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
12%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
18%
N/A
US
R
Reddit Inc
NYSE:RDDT
25.7
44%
0.6
US
Symbotic Inc
NASDAQ:SYM
18.4
22%
0.8
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1.2
16%
0.1
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
48.1
N/A N/A
P/E Multiple
Earnings Growth PEG
TH
T
T Man Pharmaceutical PCL
SET:TMAN
Average P/E: 1 420.8
Not Available 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
R
Reddit Inc
NYSE:RDDT
140.4
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 442.5 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
101.2
118%
0.9
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
Negative Multiple: -132.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
T
T Man Pharmaceutical PCL
SET:TMAN
Average EV/EBITDA: 1 288.9
32.3
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
58%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
9%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
R
Reddit Inc
NYSE:RDDT
167.8
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 220.4 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
26.8
56%
0.5
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 800.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
T
T Man Pharmaceutical PCL
SET:TMAN
Average EV/EBIT: 1 639.9
Not Available 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
99%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
8%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
R
Reddit Inc
NYSE:RDDT
178
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -553.6 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
44.1
77%
0.6
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 800.4
N/A N/A

See Also

Summary
TMAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMAN stock valuation using valuation multiples.
Wall Street Estimates
TMAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.